Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the ...

Moderna is deprioritizing its flu/COVID combination vaccine in younger adults amid a push to cut about $1.5 billion from its ...

A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...

MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic Diabetes as its chief marketing ...

Moderna also hopes that combining the shots will help improve vaccine rates. Poland, however, is not sure people will like ...

Moderna's study, involving 8,000 adults 50 and older, showed the new combo shot generated an immune response against COVID ...

An FDA committee will soon make recommendations about this fall’s Covid-19 vaccines while Novavax still awaits full FDA ...

Moderna on Thursday reported first-quarter profit and sales that beat Wall Street estimates, helped by the company's ...

Moderna has tested its first flu and COVID combination vaccine shot. Dr. Bill Hartman from UW Health joined FOX6 to talk ...

In a study published in the Journal of the American Medical Association, researchers from Moderna reported that the new combo ...

Moderna (NASDAQ:MRNA) accelerates cost cuts, trimming 2026 GAAP operating expenses by up to $500 million as COVID-19 vaccine ...